RecruitingNCT07034157

A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis


Sponsor

Beijing Anzhen Hospital

Enrollment

1,000 participants

Start Date

Jun 9, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This prospective observational cohort study aims to investigate the prevalence and clinical significance of head and neck arterial stenosis in patients with coronary artery disease (CAD) undergoing or scheduled for percutaneous coronary intervention (PCI). Using Doppler ultrasound as the primary screening tool, the study will assess the degree of stenosis and evaluate the impact of different combined treatment strategies on patient outcomes. The research will provide real-world evidence to optimize integrated care approaches for patients with comorbid cardiovascular and cerebrovascular diseases.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Age ≥18 years;
  • Patients with coronary artery disease scheduled to undergo elective percutaneous coronary intervention (PCI) on the following day.

Exclusion Criteria2

  • The expected survival is less than 1 years;
  • Simultaneously merge other serious diseases;

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPercutaneous Coronary Intervention

Coronary stenting performed as part of routine care for patients with coronary artery stenosis.

PROCEDURECerebrovascular Intervention (CAS )

Patients with intervention-indicated head and neck artery stenosis will receive carotid artery stenting based on clinical evaluation.

OTHERNo Intervention / Observation

Clinical observation or standard follow-up in patients without significant disease


Locations(1)

Beijing Anzhen Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07034157


Related Trials